Key Metrics
CiteScore 

4.1
H-Index 

29
Impact Factor 

< 5
SJR 

Q1Rheumatology

SNIP 

1.31
Recommended pre-submission checks
Powered by 

Topics Covered on Rheumatology and Therapy
Rheumatology and Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Quarterly |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Rheumatology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Rheumatology and Therapy
Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT)
- 25 Oct 2026
- Rheumatology and Therapy
Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase3 BEMOBILE1 Study.
- 23 Oct 2026
- Rheumatology and therapy
Impact of the Sociodemographic Index on Efficacy/Safety of Tofacitinib in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Phase 2/3/3b/4 Studies.
- 16 Oct 2026
- Rheumatology and therapy
Effectiveness of Newly Initiated Tofacitinib and Biologic DMARDs in Patients with Rheumatoid Arthritis.
- 15 Oct 2026
- Rheumatology and therapy
Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase3 SELECT-PsA1 Study.
- 7 Oct 2026
- Rheumatology and therapy
Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional Study
- 25 Sep 2026
- Rheumatology and Therapy
Patient-Reported Disease Activity, Health-Related Quality of Life, and Coping in Systemic Lupus Erythematosus: A Cross-Sectional Online Survey in Switzerland (Lupus-IMPACT)
- 25 Oct 2026
- Rheumatology and Therapy
Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase3 BEMOBILE1 Study.
- 23 Oct 2026
- Rheumatology and therapy
Impact of the Sociodemographic Index on Efficacy/Safety of Tofacitinib in Patients with Rheumatoid Arthritis: Post Hoc Analysis of Phase 2/3/3b/4 Studies.
- 16 Oct 2026
- Rheumatology and therapy
Effectiveness of Newly Initiated Tofacitinib and Biologic DMARDs in Patients with Rheumatoid Arthritis.
- 15 Oct 2026
- Rheumatology and therapy
Long-Term Safety and Efficacy of Upadacitinib in Patients with Psoriatic Arthritis: 5-Year Results from the Phase3 SELECT-PsA1 Study.
- 7 Oct 2026
- Rheumatology and therapy
Sociodemographic and Clinical Determinants of Colchicine Adherence in Adults with Familial Mediterranean Fever: A Cross-Sectional Study
- 25 Sep 2026
- Rheumatology and Therapy